Jiangxi Sanxin Medtec (300453.SZ) plans to invest approximately 500 million yuan in the construction of a new project industrializing high-performance blood purification equipment and supporting consumables.
Sanxin Medical (300453.SZ) announced that the board of directors has agreed to use approximately 500 million yuan of the company's own funds in Jiangxi Province...
Jiangxi Sanxin Medtec (300453.SZ) announced that the board of directors has approved the construction of the "High-performance Blood Purification Equipment and Matching Consumables Industrialization Project" in Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province, with approximately 500 million yuan of its own funds. The new project will occupy about 115 acres of land. The project will include the construction of a clean production workshop for high-performance blood purification medical equipment and matching consumables, as well as corresponding production and living facilities to increase the production capacity of blood purification critical treatment equipment and matching tubing consumables, diabetes needle-free injection systems, and matching ampoule consumables.
The announcement stated that the company's investment in the construction of the high-performance blood purification equipment and matching consumables industrialization project aims to prepare strategic resources for the company's development, leverage industry competitive advantages, and help the company smoothly achieve the strategic goal of entering the top tier of global blood purification enterprises.
Related Articles

SHANGHAI GROWTH (00770): Successfully placed 2.187 million shares of rights issue.

BOYAA (00434) plans to seek shareholders' prior approval to grant purchasing authorization for cryptocurrencies with a total purchase amount not exceeding 70 million US dollars.

BRONCUS-B(02216) plans to further acquire 3.85% equity of Valgen Holding Corporation for 55.12 million US dollars.
SHANGHAI GROWTH (00770): Successfully placed 2.187 million shares of rights issue.

BOYAA (00434) plans to seek shareholders' prior approval to grant purchasing authorization for cryptocurrencies with a total purchase amount not exceeding 70 million US dollars.

BRONCUS-B(02216) plans to further acquire 3.85% equity of Valgen Holding Corporation for 55.12 million US dollars.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


